CHINA PEDIATRIC PHARMACEUTICALS, INC.: 10-Q filed 2012-12-19
What CHINA PEDIATRIC PHARMACEUTICALS, INC. reported in its quarterly report filed 2012-12-19 (fiscal Q3 2012): 35 published measures, 99 facts as tagged in accession 0001017386-12-000392.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2012-12-19
- Fiscal period
- fiscal Q3 2012
- Accession
- 0001017386-12-000392 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHINA PEDIATRIC PHARMACEUTICALS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 16,495,942 | USD | |
| At 2011-12-31 | 22,206,598 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 14,907,180 | USD | |
| At 2011-12-31 | 20,597,650 | USD | |
| At 2010-12-31 | 23,617,351 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 987,440 | USD | |
| At 2011-12-31 | 2,186,650 | USD | |
| At 2011-09-30 | 5,029,149 | USD | |
| At 2010-12-31 | 10,992,141 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -3,580,461 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -5,818,013 | USD | 274 |
| 2011-01-01 to 2011-12-31 | -6,966,525 | USD | 365 |
| 2011-07-01 to 2011-09-30 | -4,509,657 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -731,814 | USD | 273 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | -1,211,834 | USD | 274 |
| 2011-01-01 to 2011-09-30 | -6,003,067 | USD | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 44,556,104 | shares | 92 |
| 2012-01-01 to 2012-09-30 | 44,556,104 | shares | 274 |
| 2011-07-01 to 2011-09-30 | 44,556,104 | shares | 92 |
| 2011-01-01 to 2011-09-30 | 44,496,407 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -0.08 | USD/shares | 92 |
| 2012-01-01 to 2012-09-30 | -0.13 | USD/shares | 274 |
| 2011-07-01 to 2011-09-30 | -0.1 | USD/shares | 92 |
| 2011-01-01 to 2011-09-30 | -0.02 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -0.08 | USD/shares | 92 |
| 2012-01-01 to 2012-09-30 | -0.13 | USD/shares | 274 |
| 2011-07-01 to 2011-09-30 | -0.11 | USD/shares | 92 |
| 2011-01-01 to 2011-09-30 | -0.15 | USD/shares | 273 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-09-30 | 200,825 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 811,906 | USD | |
| At 2011-12-31 | 876,900 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | 15,625 | USD | 274 |
| 2011-01-01 to 2011-09-30 | 3,017,300 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -3,580,429 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -5,817,846 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -4,756,934 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -6,268,871 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 14,172,218 | USD | |
| At 2011-12-31 | 19,619,929 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 1,588,762 | USD | |
| At 2011-12-31 | 1,608,948 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 33,744 | USD | |
| At 2011-12-31 | 314,696 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 8,991,249 | USD | |
| At 2011-12-31 | 11,946,588 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 662,920 | USD | |
| At 2011-12-31 | 177,933 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 978,954 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 5,060,695 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 2,800,076 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 9,446,182 | USD | 273 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 217,442 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 2,062,393 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 1,384,649 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 3,153,701 | USD | 273 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 711,332 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 2,868,158 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 1,306,651 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 6,006,282 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 44,556,104 | shares | |
| At 2011-12-31 | 44,556,104 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 14,102,507 | USD | |
| At 2011-12-31 | 14,102,507 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 3,150,176 | USD | |
| At 2011-12-31 | 3,038,258 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 1,727,730 | USD | |
| At 2011-12-31 | 1,719,036 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 915,824 | USD | |
| At 2011-12-31 | 842,136 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-09-30 | 1,511,818 | USD | |
| At 2011-12-31 | 1,709,769 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -3,580,461 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -5,818,013 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -4,509,657 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -530,989 | USD | 273 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -3,580,461 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -5,818,013 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -4,509,657 | USD | 92 |
| 2011-01-01 to 2011-09-30 | -731,814 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -3,612,728 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -5,706,095 | USD | 274 |
| 2011-07-01 to 2011-09-30 | -4,187,603 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 159,970 | USD | 273 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | 22,902 | USD | 92 |
| 2012-01-01 to 2012-09-30 | 69,524 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 22,971 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 69,616 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | 276,400 | USD | 274 |
| 2011-01-01 to 2011-09-30 | 270,622 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-07-01 to 2012-09-30 | -32 | USD | 92 |
| 2012-01-01 to 2012-09-30 | -167 | USD | 274 |
| 2011-07-01 to 2011-09-30 | 247,277 | USD | 92 |
| 2011-01-01 to 2011-09-30 | 5,737,882 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | -1,112,751 | USD | 274 |
| 2011-01-01 to 2011-09-30 | -4,495,373 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | -484,738 | USD | 274 |
| 2011-01-01 to 2011-09-30 | 718,986 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-09-30 | -282,924 | USD | 274 |
| 2011-01-01 to 2011-09-30 | -180,219 | USD | 273 |
Inspect the source
- Entity
- CHINA PEDIATRIC PHARMACEUTICALS, INC. / CIK 0001354071
- Captured
- SEC response SHA-256
9fa973e7cfeb332db52412b0c379de3e69dd9dc277445b38b119cd4940a59804
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001354071.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))